Photoacoustic imaging (PAI) is an emerging tool that bridges the traditional depth limits of ballistic optical imaging and the resolution limits of diffuse optical imaging. Using the acoustic waves generated in response to the absorption of pulsed laser light, it provides noninvasive images of absorbed optical energy density at depths of several centimeters with a resolution of ~100 μm. This versatile and scalable imaging modality has now shown potential for molecular imaging, which enables visualization of biological processes with systemically introduced contrast agents. Understanding the relative merits of the vast range of contrast agents available, from small-molecule dyes to gold and carbon nanostructures to liposome encapsulations, is a considerable challenge. Here we critically review the physical, chemical and biochemical characteristics of the existing photoacoustic contrast agents, highlighting key applications and present challenges for molecular PAI.
The aim of molecular imaging is to visualize and quantify biological processes at molecular and cellular levels in a noninvasive manner, thus also providing an opportunity to detect, stage, predict and monitor the development of disease. As early as the 17th century, Anton van Leeuwenhoek and Robert Hooke used light to visualize cells. Light is scattered as it passes through tissue, which leads to an inherent tradeoff between depth of penetration and spatial resolution. Microscopy and other techniques that use unscattered photons provide high-resolution (~1 μm) images, but only to a maximum depth of ~1 mm in most tissues; diffuse optical techniques such as fluorescence and near-infrared optical tomography that exploit multiply scattered photons can image to depths of several centimeters, provided spatial resolution is sacrificed 1 (>1 mm).
PAI is an emerging method that combines the high contrast of optical imaging with the high spatial resolution of ultrasound [2] [3] [4] [5] . Tissue heating due to the absorption of short laser pulses by endogenous chromophores or exogenous contrast agents produces broadband acoustic waves at megahertz frequencies. These photoacoustic (PA) waves can be detected by ultrasound transducers at the tissue surface and reconstructed to form an image of the absorbed optical energy distribution 2 . Supplementary Figure 1 and Supplementary Note 1 illustrate this process and explain the requirements for the image to represent absorbed optical energy. Because sound waves are less scattered in tissue than photons are, PAI can push the traditional limits of optical imaging. For example, when operating in the nearinfrared (NIR) window (620-950 nm), tomographic PAI can achieve a penetration depth of several centimeters with resolution on the order of a few hundred micrometers, scaling to <100 μm for shallower (<1 cm) penetration depths 3 .
PAI is currently one of the fastest-growing molecular imaging techniques. It has rapidly been adopted for preclinical in vivo imaging in small animals for a range of disease indications. The prevailing application is in cancer research, where PAI has been explored for primary tumor detection and molecular characterization 6, 7 , for therapeutic monitoring 8 and for the identification and assessment of metastatic lymph nodes 9 .
This review highlights the latest advances in exogenous contrast agents for molecular PAI. We introduce the considerations for in vivo molecular PAI; detail the physical, chemical and biochemical characteristics of available contrast agents; and provide an overview of the strengths and weaknesses of each approach. Given the widespread use of this technique in cancer research, we draw on that field for key examples of the application of molecular PAI.
SOURCES OF ENDOGENOUS CONTRAST IN PAI
Although the focus of this review is on exogenous contrast agents, it is important to appreciate the capabilities of, and challenges presented by, background endogenous PA signals in the context of molecular PAI.
Intrinsic chromophores
Endogenous PAI provides structural and functional information based on light absorption, primarily due to hemoglobin, lipids, water and melanin (Fig. 1a) . Hemoglobin, which delivers oxygen throughout the body, undergoes structural and electronic modifications after oxygen binding (Fig. 1b) . The resulting changes in its absorption spectrum (Fig. 1a) make it possible to measure the total hemoglobin concentration and oxygen saturation, which are important for studying tumor angiogenesis 8, 10 (Fig. 1c) . PAI can also be used to map lipid distribution in vivo 11 on the basis of the absorption peaks at 930 and 1,210 nm (second overtone of abundant C-H bonds), whereas water can be identified by the absorption peak at 975 nm (ref. 12) . Melanin is a ubiquitous natural pigment found in skin, hair and eyes that has intense optical absorption, enabling sensitive characterization of primary melanoma 13, 14 and metastatic melanoma cells 15 . Intrinsic chromophores it hard to distinguish from intrinsic signals, in vitro and in vivo PAI of tyrosinase-expressing cells has shown high sensitivity 23, 24 , and inducible systems can address potential toxicity concerns 25 . Despite their potential for signal amplification, enzymatic reporter systems are generally less desirable because of their dependence on substrate availability, which limits quantification.
Reporter genes are suitable for applications in which the cell or biological process of interest does not provide inherent PA contrast but use of an exogenously applied contrast agent is undesirable (for example, when it would require repeated injections, as in longitudinal studies of tumor development). They are, however, subject to the same considerations as exogenous contrast agents in terms of desired photophysical properties, as discussed in the following sections.
FACTORS IN EXOGENOUS CONTRAST AGENT DESIGN
To be useful for molecular imaging, a contrast agent (Fig. 3) must be composed of a signaling compound, which produces the signal for imaging, and a targeting moiety that enables the readout of a specific biological entity or process.
Photophysical properties
The ideal signaling compound needs to exhibit the following characteristics: a high molar extinction coefficient (Fig. 4) , to maximize the amount of light absorbed; a sharply peaked, characteristic absorption spectrum, to ensure unambiguous identification by spectral unmixing even at low molar concentrations (Supplementary Note 1); peak absorption in the NIR window (620-950 nm), to maximize penetration depth by avoiding the strong absorption of intrinsic chromophores (Fig. 1a) ; high photostability, to ensure that spectral features are not changed by light irradiation; low quantum yield, to maximize the nonradiative conversion of light energy to heat; and efficient conversion of heat energy 3 to produce acoustic waves.
Biological properties
The targeted contrast agent must overcome circulatory and cellular barriers (Supplementary Fig. 2) . Contrast agents will first interact with biomolecules in the bloodstream 26, 27 , where adsorption of biomolecules onto the surface of the agent affects both immune responses and target binding 27, 28 . This requires characterization and consideration in the interpretation of biological results. For extravasation from the circulatory system to extravascular targets, a maximum size of typically <10 nm is necessary. For applications in cancer, contrast agents up to 100 nm in size have been found to pass through the leaky vessels in tumors 29 . Once in the tissue interstitium, the agent can pass through the cellular barrier by active targeting-for example, to cell surface receptors 30 , transporters 31 or metabolic enzymes 32 -or by relying on passive uptake through diffusion or endocytosis.
To facilitate active targeting, the biological target should be (over) expressed at an early stage of the disease and found at low levels in off-target tissues. Structures that can be used to achieve active targeting include small molecules, peptides and adhirons 33 , affibodies 34 , aptamers 35 and proteins (Fig. 3) . In particular, consideration must be given to biocompatibility, which in this context refers to minimizing toxicity (for example, through control of the administration route and dose) and immune response (for example, by reducing accumulation in off-target tissues), as well as optimizing elimination from the circulatory system and target tissue penetration.
For example, combining small molecules such as sugars with small-molecule dyes results in a small (<1 nm) contrast agent that can easily pass through physiological barriers and be cleared rapidly through the kidneys, which reduces off-target accumulation and optimizes biocompatibility. Conversely, although proteins (for example, monoclonal antibodies) show high target affinity and specificity, and thus display little cross-reactivity with healthy tissues, their larger size results in poorer tissue penetration and clearance, and immunogenicity is possible, resulting in poorer biocompatibility. Antibody fragments, including diabodies and nanobodies, are now being developed to address these challenges, as they are smaller in size but retain high affinity and selectivity 34, 36 . 
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For cancer research, the hyperpermeability of tumor vasculature combined with the lack of intact lymphatic drainage may lead to enhanced permeability and retention (EPR) of contrast agents up to ~100 nm in size inside the tumor tissue without the need for targeting ligands 37 . 'Passive' targeting based on EPR has been demonstrated extensively in mice (Supplementary Tables 1-4) , and recently the first studies in humans have begun to emerge 38 . Larger entities (>100 nm) typically do not accumulate and will be cleared through the reticuloendothelial system 29 . Passive targeting confounds attempts to perform targeted molecular imaging, as uptake is not specific to a biological process, and thus it should be avoided as much as possible via contrast-agent design.
SIGNALING COMPOUNDS FOR MOLECULAR PAI
Signaling compounds fall into three broad classes: small-molecule dyes, metallic or semiconducting nanostructures, and organic nanostructures (Fig. 3). Supplementary Tables 1-4 summarize PAI studies using different classes of compounds. Figure 4 offers a direct comparison of two critical parameters for the ideal signaling compound: the specific extinction coefficients and peak absorption wavelengths.
Small-molecule dyes
Small-molecule NIR dyes 39 (Supplementary Table 1 ) are generally commercially available. The chemical basis of these dyes is a series of conjugated double bonds and/or (mostly aromatic) ring systems. In these highly conjugated structures, electrons are delocalized, meaning less energy is needed for excitation. The welldefined energy gap between the ground and excited states results in a distinct absorption peak (Supplementary Fig. 3) . Relaxation of the excited electrons can occur in radiative (fluorescence or bioluminescence) or nonradiative processes, depending on the lifetime and electronic configuration of the excited states 40 (Fig. 5a) . For PAI, a large nonradiative relaxation is required, so the quantum yield (referring to fluorescence emission) should be as low as possible.
The first main class of NIR dyes used for PAI is the heptamethine cyanine dyes comprising two aromatic nitrogen-containing heterocycles linked by a heptamethine chain 41, 42 . An example is indocyanine green (ICG), a US Food and Drug Administration-approved dye with low toxicity. In aqueous solution, ICG has an absorption maximum at 780 nm and a relatively low quantum yield for fluorescence 43 (0.027). Because of its inherent hydrophobicity, ICG exhibits high plasma protein binding and is used clinically as a blood flow contrast agent 44 . ICG was rapidly adopted for cancer research studies using PAI for identification of the closest 'sentinel' lymph node in the lymphatic drainage from a tumor 45 , which is crucial for cancer staging. However, the hydrophobicity of ICG (and other small-molecule dyes) can result in substantial concentration-and environment-dependent changes in optical properties 46 (Fig. 5b) , as well as photoinstability. Also, the functionalization and targeting chemistry of ICG is challenging; unmodified ICG is therefore not ideal for molecular PAI 47, 48 , and alternative heptamethine cyanine dyes have been used for this purpose (Supplementary Table 1) .
Squaraines are the second main class of NIR dyes that could be used for molecular PAI. They are characterized by an electrondeficient central four-membered ring that is often conjugated to REVIEW npg two electron-donating groups to generate a donor-acceptor-donor form, which increases the delocalization of the electrons. The optical properties can be tuned by variation of the donor strengths to produce sharp absorption bands in the NIR range 49 . Despite their good optical properties and photostability, squaraines are often limited by insolubility, aggregation and chemical reactivity 50, 51 . In PAI they have been used only in conjunction with phospholipids, albumin or polymers owing to poor solubility [52] [53] [54] . Additional dye classes with fewer examples in PAI are rhodamines and azo dyes. Rhodamines are characterized by a xanthene core unit with dialkylamino groups and have good photostability 55 , but few have been reported in the NIR range. Azo dyes methylene blue (664 nm) and Evans blue (620 nm) have been used for PAI but are limited by their relatively blueshifted absorption peaks 56, 57 and potential to cause photodamage under intense irradiation 58 .
Challenges associated with the use of small-molecule dyes include a low molar extinction coefficient (<3 × 10 5 M -1 cm -1 ) and low solubility along with a tendency to aggregate and photobleach. It is possible to address some of these challenges chemically, by attaching hydrophilic groups, introducing triplet-state quenchers 59 and integrating stabilizing groups 60 . Additionally, variations in chemical design, such as varying the size of the conjugated system and attaching electron-donating or electron-withdrawing groups, can be used to tailor the spectral range. Their chemical flexibility also facilitates the creation of 'smart' contrast agents (see "Emerging concepts in molecular PAI"), which can in part compensate for their low molar extinction coefficient by minimizing the influence of the background signal from endogenous chromophores.
Most small-molecule dyes must be actively targeted to gain specificity. A common target for the detection and characterization of solid tumors in preclinical research is the cell-surface epidermal growth factor receptor (EGFR), which is frequently overexpressed. Hudson et al. 61 explored the potential of molecular PAI for detecting EGFR-expressing tumors in a mouse model of pancreatic cancer (at depths of >5 mm) by conjugating the epidermal growth factor (EGF) protein to the rhodamine NIR dye CF-750 (Fig. 5c) . The absorption spectrum of CF-750 was not significantly altered by the bioconjugation to EGF, and the probe signal could be clearly distinguished from background by multiwavelength PAI, providing a noninvasive readout of EGFR expression. Importantly, there was no noted toxicity.
In spite of their photophysical limitations, small-molecule dyes remain good candidates for molecular PAI in preclinical studies of extravascular targets owing to their small size and favorable biocompatibility.
Nanostructures
Nanoparticles (NPs) are currently the largest class of contrast agents for molecular PAI. They possess high chemical, physical and biochemical flexibility, as well as substantially increased molar extinction coefficients compared to those of small-molecule dyes. NPs exist in different materials, shapes and sizes (<1,000 nm, usually ~10-100 nm) and have tunable surface properties, reactivity and optical characteristics. Their large surface area means a large number of targeting moieties can be attached per particle, increasing the probability of target-binding. However, because of their larger size, NPs often accumulate in the reticuloendothelial system for long time periods, yielding poorer biocompatibility. Furthermore, the reproducibility, purification and quantification of homogeneous, well-defined NPs remain challenging 62 . Details of common synthesis routes for all nanostructures and nanomaterials demonstrated for PAI can be found in Supplementary Notes 2 and 3.
Gold. The main focus of research into metallic NPs for molecular PAI has been on gold, owing to its unique optical and physicochemical properties, relatively inert nature and prior use in humans. In addition, gold forms strong gold-thiolate bonds that enable covalent surface modifications for optimizing biocompatibility (e.g., polyethylene glycol (PEG) functionalization) 63 , stability (e.g., silica encapsulation) 64 and active targeting.
The optical properties of gold NPs (GNPs) arise from the 'localized surface plasmon resonance' (LSPR) phenomenon. The conduction electrons of a GNP oscillate relative to the core when exposed to light of an appropriate wavelength (Fig. 6a) . This state is referred to as a plasmon 65 . Plasmons convert a substantial part of the oscillation energy into heat detectable with PAI. The key advantage of GNPs for PAI signal generation is that they essentially act as a macroscopic dipole, leading to an extinction coefficient several orders of magnitude higher than that of small-molecule dyes (extinction scales ~ volume 3 ) 66 . GNPs show the highest extinction coefficient in the NIR range and high PA conversion efficiency.
The frequency of the LSPR determines the peak absorption wavelength of the GNP, which can be tuned on the basis of surface-to-volume ratio, polarization modes, edge/vertex number and 'sharpness' of the GNP. Therefore, in addition to spheres, a wide range of GNP Table 2 ). A key example of tuning is found in gold nanorods (GNRs), which have intense and narrow LSPR absorption bands in the NIR range that can be tuned through variation of their aspect ratio (Fig. 6b) . GNRs are commonly encapsulated in silica, which reduces the gold's interfacial thermal resistance with the solvent, thereby improving the PA conversion efficiency 64, 67 and photostability 68 . Another example is the use of hollow gold nanostructures, such as gold nanocages and gold nanoshells, that can also encapsulate cargo such as drugs within their porous walls. The LSPR frequency can be conveniently tuned on the basis of not only size but also shell thickness (thinner shells lead to a red shift) 69, 70 (Fig. 6c) . These simple methods for tuning the characteristic spectral shape and peak wavelength are highly advantageous for molecular PAI.
In diseases that involve a leaky vasculature, such as cancer, GNPs can accumulate via the EPR effect 71 . Actively targeting the angiogenic tumor vasculature (in contrast to quiescent surrounding vessels) provides a tumor-specific readout that circumvents the physiological barrier of extravasation into the tissue. The tripeptide arginine-glycineaspartic acid (RGD) and its derivatives are widely used to target the α v b 3 integrin on angiogenic vessels. All studies to date have used a bifunctional PEG linker to conjugate the GNP with the RGD derivative (Supplementary Table 2 ). Studies with larger RGD-modified GNPs suffer from high GNP accumulation in the reticuloendothelial system and slow tumor accumulation of at least 6 h (refs. 30, 72) . This is unfavorable in terms of biocompatibility, as it renders the reticuloendothelial system prone to oxidative damage via free radical formation 73 . These limitations were recently overcome through the use of small gold tripods (<20 nm) conjugated to the RGD derivative cyclic Arg-Gly-Asp-D-Phe-Cys via a PEG linker 74 (Fig. 6d,e) . PAI results were verified with 64 Cu positron-emission tomography. Encouragingly, RGD-gold tripods showed rapid accumulation in a U87MG glioma within 2 h without systemic toxicity.
Targeting of GNRs to extravascular cell-surface receptors has been demonstrated using antibody conjugation. Because of their relatively narrow spectrum, GNRs tuned to absorb at a range of different peak wavelengths can be conjugated to multiple targets, which has enabled multiplexed characterization of tumor EGFR and human epidermal growth factor receptor 2 (HER2) expression 7 , allowing characterization of heterogeneous tumors and specific tracking of combination therapies. It remains to be seen whether the use of GNPs in reaching extravascular targets is generalizable across disease types and to applications in healthy tissue with intact vasculature.
GNPs possess the most flexible photophysical properties of the compounds reviewed. Easy and stable functionalization of GNPs can be accomplished via gold-thiolate bonds, suitable for attachment of a range of targeting moieties and additional signaling compounds for multimodal imaging. Their associated spectral flexibility makes GNPs highly suitable for multiplexed imaging of different targets within the same tissue. Nonetheless, interaction of the GNPs reviewed here within vascular and tissue compartments depends on their size, shape, charge and synthesis route. Biocompatibility in vivo therefore needs to be more systematically addressed through longerterm toxicity studies for individual nanostructures. Table 3 ). All three classes can be synthesized to possess an intrinsic absorption in the NIR range (Fig. 7a,b,  Supplementary Fig. 4 and Supplementary Note 2). Despite possessing a lower molar extinction coefficient than gold, carbon NPs (CNPs) hold much potential for molecular PAI owing to their flexibility of synthesis and functionalization. Of particular interest is the wide variety of covalent [75] [76] [77] [78] and noncovalent modifications with small molecules (dyes 79 , drugs 80 or surfactants 81 ), polymers 79 and biomolecules 82 that can be used for targeting, increased solubility and stability 83 , improved signaling properties 84 or increased specificity 79 . The absorption spectra of CNPs tend to be relatively broad in the NIR range, presenting a challenge for spectral unmixing in molecular PAI, but this limitation can be circumvented via the attachment of NIR dyes (Supplementary Fig. 5 ).
Carbon. Carbon forms different allotropic structures: carbon nanotubes, graphene-based nanomaterials and nanodiamonds (Supplementary
The majority of molecular PAI studies using carbon have been performed with single-walled carbon nanotubes (SWNTs). SWNTs can be visualized as cylindrically rolled-up graphene sheets with diameters of 1-3 nm and lengths up to centimeters 85 ( Fig. 7a) . Semiconducting SWNTs can exhibit numerous optical absorption peaks (Fig. 7a,b) . These absorption peaks are defined by narrow energy ranges where many electronic states are available (referred to as van Hoff singularities; Fig. 7b) . The electronic, and thus optical, properties can be tuned through changes to the tube structure (for example, diameter and chirality). The band gap generally varies inversely with the diameter, but many REVIEW npg open questions remain regarding the complex photophysics of SWNTs 86, 87 . Molecular targeting of the α v b 3 integrin for angiogenesis imaging has been achieved in multiple studies of CNPs using RGD peptides attached to SWNTs 79, [88] [89] [90] . De la Zerda et al. 88 conjugated RGD peptides through PEG-grafted phospholipids to SWNTs. In vivo evaluation found a strong PAI signal in the tumor for RGD-SWNTs, compared to only weak signals (via passive EPR uptake) for nontargeted SWNTs (Fig. 7c) . Attachment of NIR dyes to the surface of the nanotubes yielded substantial PA contrast and subnanomolar sensitivities in mice compared to plain SWNTs 79, 90 . The underlying mechanism of the enhancement was not established, but quenching effects between the dyes and SWNTs may have had a role. It should be noted that photobleaching can occur because of the instability of the dyes associated with these constructs.
Researchers have also specifically targeted SWNTs to tumors overexpressing the cell surface glycoprotein CD44 by coating them with a hyaluronic-acid-based biosurfactant. The coating is degraded by hyaluronidases overexpressed in cancer cells. Further labeling of the hyaluronic acid unit with a fluorescent dye was used to provide validation of the selective CD44 receptor uptake using PAI and fluorescence imaging 83 illustrating controlled SWNT delivery.
Although CNPs are generally limited by their broadband absorption profile and low molar extinction coefficient (similar to dyes), they offer high photostability and versatile routes for functionalization and tailoring of spectral properties. Limited investigations of biocompatibility suggest that as with GNPs, surface modification, size, shape and synthesis method are all relevant 91 . Several studies have reported cytotoxicity and inflammatory potential of SWNTs 92, 93 , although this can be substantially reduced by functionalization 94, 95 . In contrast, emerging evidence suggests that nanodiamonds exhibit high biocompatibility [96] [97] [98] . Significant future effort is needed to better understand CNPs' photophysics and potential for biocompatibility. Table 4 ). These have high structural and functional flexibility (e.g., with respect to composition, shape, charge and size) and can act directly as signaling compounds, enhance the biocompatibility of other signaling compounds or act as a foundation for activatable imaging probes in PAI. The most popular organic polymer structures for PAI contain either conjugated polymers or porphyrin-related units (Supplementary Fig. 6 ), which directly absorb light. Their molar extinction coefficient sits between those of small-molecule dyes and GNPs (Fig. 4) , and although their absorption spectra may be broad, they usually exhibit an absorption peak in the NIR range (Fig. 7d) and are relatively photostable. Furthermore, their chemically and physically stable polymeric platform provides the opportunity to attach specific targeting and therapeutic moieties (Supplementary Note 2) . 
Organic nanostructures. An exciting recent development in molecular PAI is the use of polymer NPs and encapsulations (Supplementary
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Polymer NPs come in many different flavors. Conjugated polymers (CPs) are macromolecular structures with a highly delocalized conjugated backbone (Supplementary Fig. 6a) . The conjugated system is spread through the entire polymer backbone and the polymers are densely packed into NPs, yielding much higher extinction coefficients and photostability than possible with smallmolecule dyes. One can tune the optical properties (which are strongly dependent on the conjugated core) by adopting different backbone structures, combining different conjugated polymers, and controlling aggregation and surface functionalization [99] [100] [101] . As an example, polypyrrole NPs are advantageous for PAI because of their intense NIR absorption, high photothermal conversion efficiency and photostability, without acute toxicity 102 . They can be well dispersed in aqueous solution 102 but lack functional groups for surface modification. Alternative CPs are now being developed, characterized by an alternating electron-donor-acceptor structure that shifts the absorption toward longer wavelengths and allows the addition of functional units 103, 104 (Supplementary Fig. 6b) . Compared with SWNTs and GNRs, these alternative CPs have been shown to yield fourfold higher PAI signal in vivo on a per-mass basis, but lower signal than GNRs when compared on a molar basis 104 . They can also act as 'smart' contrast agents (see "Emerging concepts in molecular PAI"), for example, for in vivo real-time imaging of reactive oxygen species 104 .
Alternatives to synthetic CPs are the naturally occurring porphyrins, aromatic macrocycles from heme and chlorophylls containing four pyrrolic units linked by methane (Supplementary Fig. 6a ).
Whereas CPs often possess a broadband absorption profile, porphyrin NPs show a narrow absorption peak in the NIR range, allowing for clearer identification in PAI (Fig. 7d) . The chemical characteristics of the porphyrin macrocycle offer architectural flexibility, which permits tuning of the optical properties (Supplementary Fig. 6b) . As with uncoated CP NPs, unmodified porphyrins are insoluble. Lovell et al. 105 overcame this challenge by conjugating porphyrin to a phospholipid, which resulted in self-assembled porphysomes with a bilayer structure. The porphyrin molecules inside the porphysome create J-aggregates, red-shifting the absorption peak (Supplementary Fig. 6b ) and causing fluorescence quenching to yield a strong NIR PA signal 105, 106 . The porphyrin-lipid shell has also been used for encapsulation of carboxyfluorescein, doxorubicin 105 and fluorinated gases, enabling multimodal PAI, ultrasound and fluorescence imaging 107, 108 . As natural products, poryphyrins and porphysomes would be expected to show high biocompatibility, but because of their relative immaturity as contrast agents, this has yet to be established in vivo.
For other polymers lacking intrinsic optical absorption but showing favorable biocompatibility, signaling compounds can be incorporated through micellar or vesicular structures, which can also be used for targeted delivery of compounds. Gold nanobeacons are formed from small GNPs (2-4 nm) trapped within synthetic or natural amphilines, forming NPs 60-260 nm in size 109, 110 . Advantages of such formulations include improved photostability, biocompatibility, signal intensity and targeting ability compared with the signaling compound alone. Disadvantages include the presently limited knowledge of how polymer NP structure and local signaling compound concentration influence PA signal generation, as well as the larger size of the encapsulation. Despite their early stage of development, polymers and encapsulations have been used in numerous passive targeting applications, such as imaging mouse brain vasculature 102, 111 , tumor sentinel lymph node identification 104, 105, 112 and primary tumor characterization [113] [114] [115] . Wang et al. 116 actively targeted folate-receptorpositive MCF-7 breast cancer xenografts with poly(d,l-lactideco-glycolide) (PLGA) lipid NPs containing ICG for PA signal and folic acid for targeting (Fig. 7e) ; the fabricated NPs showed good stability, high folate-receptor targeting efficiency and good PA signal in vitro and in vivo (Fig. 7f) . Conjugation of polypyrrole NPs to the same target has also been demonstrated 103 . In that study, biocompatibility was assessed only in cells in vitro; studies in vivo were limited to evaluations of biodistribution, which showed the expected involvement of the reticuloendothelial system in contrastagent clearance 103 .
The stable polymeric platform provides exciting opportunities to attach not only active targeting moieties but also activatable functionalities for smart probes (see "Emerging concepts in molecular PAI"). Because this class of contrast agents is relatively new, detailed biocompatibility studies to prove their potential for in vivo application in molecular PAI are still lacking. Further work to develop biocompatible platforms with even higher NIR absorption and multifunctional capability is expected to appear in the coming years.
EMERGING CONCEPTS IN MOLECULAR PAI
Smart (or 'activatable') contrast agents elicit a prescribed signal change, such as a shift in the peak absorption wavelength, in response to a biological stimulus of interest. As well as increasing the range of possible molecular imaging targets, a key advantage of smart contrast agents is that they minimize the influence of the background signal from endogenous chromophores, and thus offer the potential for high sensitivity of detection. Their dynamic response also facilitates real-time studies of processes such as enzymatic activity. Although relatively few examples exist so far for PAI, targeting proteases such as matrix metalloprotease 6 and furin 32 have shown promise. In smart contrast agents, the protease substrate (a short peptide) links a quencher (BHQ3) with either a fluorophore (Alexa Fluor 750) 6 or an NP (CuS) 117 . PA images acquired at the peak wavelengths of the two absorbers both show strong signals before the contrast agent reaches the target. Inside the tumor microenvironment, proteases cleave the linker, leaving only one absorption peak after cleavage, yielding a highly specific imaging approach to quantify protease activity noninvasively. Undesirable toxicity in off-target tissues with high physiological protease levels has yet to be assessed.
With multimodality contrast agents, it is possible to image the same target with two or more approaches (to overcome the weaknesses of each modality) or to read out multiple targets, building a more complete picture of the underlying biochemistry. Molecular imaging modalities can differ in sensitivity by up to six orders of magnitude 118 , necessitating a difficult compromise to satisfy the concentration requirements for each modality. Although PAI has been combined with positron-emission tomography 74 and/or MRI 119, 120 for whole body imaging to determine the biocompatibility of contrast agents, its natural partners are ultrasound and fluorescence imaging because of the acoustic detection and optical excitation paths. Several PA and contrast-enhanced ultrasound contrast agents are available 9, 108 . Small-molecule dyes used for PAI are also fluorescent, which can facilitate ex vivo validation of contrast-agent biodistribution in whole organs and tissue sections.
OUTLOOK: PROMISE AND FUTURE CHALLENGES
PAI is an exciting new modality that uses non-ionizing radiation for real-time imaging with high spatial resolution and penetration depth. A broad range of application areas for molecular PAI have been identified, including oncology, neuroscience and cardiovascular diseases; so far basic research studies and preliminary clinical trials have focused primarily on detection, staging and therapeutic monitoring in cancer.
Despite great progress in the development of molecular PAI contrast agents in recent years, several challenges must be overcome to facilitate uptake into basic research in the life sciences. It is crucial that researchers recognize the need for standardized reporting of experimental approaches, for example, with regard to measured photophysical properties. Publications should report in detail the calculations of extinction coefficients on both a per-mass and a permole basis, along with independent measurements of both optical and photoacoustic absorption spectra as a function of concentration and solvent. These factors have a major impact on biocompatibility, as detection sensitivity in vivo is intrinsically linked to administered dose. Systematic chemical studies to improve solubility, stability and specific targeting capability are needed across all classes of contrast agents, as is the development of reproducible, cost-effective and scalable chemical syntheses and purification methods.
Even with photophysical and chemical characteristics optimized, criteria related to targeting and biocompatibility must be fulfilled. The large size of nanostructures relative to physiological barriers may limit their use with intravascular targets for molecular imaging applications beyond cancer. Methods for nanostructure self-assembly in vivo may overcome such limitations. To provide convincing evidence of active targeting, both intra-and extravascular, studies must include both cellular controls (for example, knockdowns of the biological target) and physiological controls (for example, blocking with competing ligands). Although the nanostructured materials reviewed here are often claimed to be inert, biocompatibility seems to be strongly dependent on the nanostructure size, shape and synthesis method used in their preparation. In future studies, biological interactions, immunogenicity, stability, circulation and target-tissue retention must be characterized for individual nanostructures to define their safety profiles; relying on general literature for the nanostructure class is insufficient. Assessment of biocompatibility at both cellular (in vitro) and organismal (in vivo) levels is needed, including blood sampling and tissue analysis to identify potential acute and chronic inflammatory and toxicity effects.
Once biocompatibility concerns are addressed, molecular PAI will then have to achieve technical and biological validation before it can gain acceptance as a routine tool. Technical validation requires assessment of precision (repeatability/reproducibility) and accuracy (the ability to relate the imaging signal to the abundance of chromophore). Although substantial efforts have been made relating to the accuracy of PAI 121 , there remains a paucity of data relating to precision. Key to routine application of molecular PAI is biological validation of the sensitivity and specificity of the readout in relation to the target biological entity or process. Comparisons of contrast agents would benefit from standardization (for example, through the use of published recommendations 122 ) with regard to the disease model, tumor sizes, time points and reported metrics. The current review has also highlighted the near ubiquitous use of simple animal models, including subcutaneous xenograft tumors. Immunodeficient nude mice are also used routinely, as they allow researchers to avoid the effect of skin melanin on optical absorption and minimize interactions with the immune system. Although these systems provide an acceptable proof of concept, translation of findings to transgenic mouse models on immune-competent backgrounds (for example, C57BL/6) will ultimately be needed for widespread uptake of the technique in preclinical research.
The exogenous contrast agents described here are still in the early stages of exploration, and mostly have been demonstrated only in single proof-of-concept studies. Opposing the current trend toward vast increases in the number of different signaling compounds available, we believe that to maximize impact in preclinical molecular imaging, it is crucial to better understand the photophysical and biological properties of the promising classes that have already been reported, to enable their routine use. Lessons learned from other areas of molecular imaging indicate that the field might make good progress by focusing development and commercial efforts on contrast agents that prove successful in rigorous studies of biocompatibility and achieve biological validation in realistic animal models of disease.
The advantages of molecular PAI can be appreciated across diverse applications. Here we have highlighted applications in detection of angiogenic vasculature, evaluation of heterogeneity in tumor cell receptor expression and visualization of protease activity. Contrast agents that meet both the photophysical and the biological requirements set out in this review are likely to emerge in the near future. Such agents could rapidly advance studies of targeted cancer therapies, perhaps even tracking immune cell infiltration and activation in tumor models at high resolution to advance understanding of the mechanisms of action and resistance for immunotherapy. 
